Pfizer and BioNTech on Tuesday submitted initial data on their coronavirus vaccine for children aged 5 to 11 to the U.S. Food and Drug Administration, Axios reports.
Gallup: “A steady 55% of parents in the U.S. with children under 12 say they would get their child vaccinated against the coronavirus if such a vaccine were available.

Save to Favorites
